about
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical n...
Read More
3.34
0.05
(1.52%)
8.9M
XNAS Volume
High volume today
XNAS 25 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..